Pipeline

Our lead product, MelCancerVac® has been tested in clinical trials for the treatment of two different types of cancer, colorectal cancer (CRC) and non-small-cell lung cancer (NSCLC).

CRC Clinical Trials

• Phase II at Gentofte Hospital, Denmark Completed
• Phase II at the National Cancer Centre, Singapore Completed

NSCLC Clinical Trials

• Phase II at Herlev Hospital, Denmark Completed